Australia's Imagion Biosystems up on deal to develop breast cancer treatment

Imagion Biosystems

12/08/2021 06:15

** Shares of Imagion Biosystems  IBX.AX  jump as much as 9%
to A$0.085, their highest since July 23 
    ** The medical devices maker signs agreement with
biopharmaceutical co Global Cancer Technology (GCT) to develop
nanoscintillator technology for treating breast cancer
 urn:newsml:reuters.com:*:nASX2zrXNq
    ** IBX says GCT's nanoscintillator tech has the potential to
deliver a more localized and effective dose of the drug product
to treat cancers
    ** About 8.5 mln shares change hands, vs the 30-day average
volume of 5.4 mln shares
    ** IBX is down 46.2% this year, as of last close
    
  

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))